ctDNA as a Biomarker for Treatment Response in HNSCC

NCT03540563 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Netherlands Cancer Institute